2
Total deals
$595.0M
Total value
$595.0M
Avg deal
$595.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
SAGA Diagnostics
Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitorin…
|
2026-04-16 | Merge | Pending | $595.0M | Deal → |
| 2 |
Lexent Bio
Lexent Bio is building novel liquid biopsy technology to change the way we diagn…
|
2020-06-12 | Acquisition | Complete | — | Deal → |